BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24965108)

  • 1. Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma.
    Guo Y; Arakawa F; Miyoshi H; Niino D; Kawano R; Ohshima K
    Pathol Int; 2014 Jun; 64(6):263-6. PubMed ID: 24965108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.
    Koo GC; Tan SY; Tang T; Poon SL; Allen GE; Tan L; Chong SC; Ong WS; Tay K; Tao M; Quek R; Loong S; Yeoh KW; Yap SP; Lee KA; Lim LC; Tan D; Goh C; Cutcutache I; Yu W; Ng CC; Rajasegaran V; Heng HL; Gan A; Ong CK; Rozen S; Tan P; Teh BT; Lim ST
    Cancer Discov; 2012 Jul; 2(7):591-7. PubMed ID: 22705984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.
    Sim SH; Kim S; Kim TM; Jeon YK; Nam SJ; Ahn YO; Keam B; Park HH; Kim DW; Kim CW; Heo DS
    Am J Pathol; 2017 May; 187(5):980-986. PubMed ID: 28284718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.
    Bouchekioua A; Scourzic L; de Wever O; Zhang Y; Cervera P; Aline-Fardin A; Mercher T; Gaulard P; Nyga R; Jeziorowska D; Douay L; Vainchenker W; Louache F; Gespach C; Solary E; Coppo P
    Leukemia; 2014 Feb; 28(2):338-48. PubMed ID: 23689514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
    Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
    Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan.
    Kimura H; Karube K; Ito Y; Hirano K; Suzuki M; Iwata S; Seto M
    Leuk Lymphoma; 2014 Apr; 55(4):962-3. PubMed ID: 23808814
    [No Abstract]   [Full Text] [Related]  

  • 7. A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway.
    Mao Y; Wang J; Zhang M; Fan W; Tang Q; Xiong S; Tang X; Xu J; Wang L; Yang S; Liu S; Xu L; Chen Y; Xu L; Yin R; Zhu J
    Oncotarget; 2017 Feb; 8(7):10954-10965. PubMed ID: 28009988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
    Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
    Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.
    Dobashi A; Tsuyama N; Asaka R; Togashi Y; Ueda K; Sakata S; Baba S; Sakamoto K; Hatake K; Takeuchi K
    Genes Chromosomes Cancer; 2016 May; 55(5):460-71. PubMed ID: 26773734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type.
    Liu J; Liang L; Li D; Nong L; Zheng Y; Huang S; Zhang B; Li T
    Oncol Rep; 2019 Jun; 41(6):3219-3232. PubMed ID: 31002364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan.
    Hongyo T; Li T; Syaifudin M; Baskar R; Ikeda H; Kanakura Y; Aozasa K; Nomura T
    Cancer Res; 2000 May; 60(9):2345-7. PubMed ID: 10811105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.
    Tsuyama N; Asaka R; Dobashi A; Baba S; Mishima Y; Ueda K; Oguchi M; Tsuji H; Hatake K; Takeuchi K
    Hematol Oncol; 2018 Feb; 36(1):328-335. PubMed ID: 28695659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models.
    Rivera-Munoz P; Laurent AP; Siret A; Lopez CK; Ignacimouttou C; Cornejo MG; Bawa O; Rameau P; Bernard OA; Dessen P; Gilliland GD; Mercher T; Malinge S
    Blood Adv; 2018 Jul; 2(13):1616-1627. PubMed ID: 29986854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing.
    Yim J; Koh J; Kim S; Song SG; Bae JM; Yun H; Sung JY; Kim TM; Park SH; Jeon YK
    Am J Surg Pathol; 2022 Apr; 46(4):486-497. PubMed ID: 34980830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathology, immunophenotype, T cell receptor gene rearrangement, Epstein-Barr virus status and p53 gene mutation of cutaneous extranodal NK/T-cell lymphoma, nasal-type.
    Wang TT; Xu C; Liu SL; Kan B; Ran YP; Liu WP; Li GD; Wang L
    Chin Med J (Engl); 2013 Apr; 126(7):1281-7. PubMed ID: 23557559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated JAK3 mediates growth advantage and hemophagocytosis in extranodal nasal-type natural killer/T-cell lymphoma.
    Picod A; Martino S; Cervera P; Manuceau G; Arca M; Wittner M; Zhang Y; Liang H; Beghi F; Solary E; Louache F; Coppo P
    Haematologica; 2022 Sep; 107(9):2218-2225. PubMed ID: 35511669
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequent Mutations in Natural Killer/T Cell Lymphoma.
    Zhang Y; Li C; Xue W; Zhang M; Li Z
    Cell Physiol Biochem; 2018; 49(1):1-16. PubMed ID: 30134235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
    Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
    Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
    Donner LR
    Pediatr Dev Pathol; 2008; 11(4):325; author reply 326. PubMed ID: 18839448
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular underpinning of extranodal NK/T-cell lymphoma.
    Huang Y; de Leval L; Gaulard P
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):57-74. PubMed ID: 23768641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.